The objective of the study is to determine if the addition of peritoneal ultrafiltration to
standard therapy in treatment-resistant severe heart failure patients will improve fluid
balance and functional capacity such that they will spend less time in the hospital and have
an improved ambulatory quality of life in comparison to patients who remain on standard
therapy alone.